However, the post-transplantation efficacy for SM with AML1::ETO + AML patients remains suboptimal, as relapses post-transplantation often result in treatment failure.The persistence of MCs in patients undergoing allo-HSCT represents an intriguing clinical observation (5). Here, RUNX1T1 is linked to acute myeloid leukemia.